×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [objective response rate]
Nuovi inibitori irreversibili di EGFR Cesare Gridelli Division of Medical Oncology “S.G. Moscati” Hospital – Avellino (Italy)
[email protected]
[email protected]
212 views
Chondrosarcoma
24 views
Abstract #LBA7511
28 views
Castrate-resistant prostate cancer (CRPC). disease progression despite androgen depletion therapy (ADT) present as : 1. continuous rise in PSA 2. progression
219 views
TRIAL UPDATE SESSION Chair: Dr Julie Martyn ANZGOG ANNUAL SCIENTIFIC MEETING 21-23 March 2013 Broadbeach Queensland
218 views
A Phase II Trial of Sunitinib (S) in Previously-Treated Pancreas Adenocarcinoma (PAC), CALGB 80603 E.M. O’Reilly, D. Niedzwiecki, D. Hollis, T. Bekaii-Saab,
216 views
Adam Heathfield, PhD Senior Director, Worldwide Policy, Pfizer Inc. September 25, 2013 Personalised Medicine – an industry perspective
218 views
Personalized Therapy of Lung Cancer 2011 Winter Lung Cancer Conference Thomas J. Lynch, Jr., M.D. Jonathan and Richard Sackler Professor of Internal Medicine
219 views
1 Coiffier B et al. J Clin Oncol 2012;30(6):631-6 . Proc ASH 2011;Abstract 591
44 views
Background
31 views
1 Precision Medicine in Advanced Non- Small Cell Lung Cancer A therapy that works…so lets get the most out of it that we can Gary Middleton, University
220 views
Novel Her-2- neu Targeted Agents Jame Abraham, M.D, FACP Bonnie Wells Wilson Distinguished Professor Chief, Section of Hematology-Oncology West Virginia
221 views
< Prev
Next >